IHC - CD61

This test requires a tissue sample. The method of obtaining this sample will vary depending on your specific circumstances.

In the IHC - CD61 test, a tissue sample is fixed, sectioned, and incubated with an antibody that binds to the CD61 antigen. The bound antibody can then be visualized under a microscope.

Any discomfort associated with the IHC - CD61 test is typically related to the procedure used to collect the tissue sample. The sample collection method can vary, and may sometimes require a local anesthetic to minimize discomfort.

Your doctor may order an IHC - CD61 test if they suspect a condition that may be affecting your platelets or if they want to gain more information about a certain type of cancer.

Abnormal results may indicate that a higher or lower than expected number of cells in your tissue sample are expressing CD61. This could suggest a potential health condition that needs further investigation.

No specific preparation is needed before the IHC - CD61 test.

The primary risks associated with the IHC - CD61 test are those related to the procedure used to collect the tissue sample. These can include potential complications such as infection , bleeding, or pain at the site of the procedure.

Your healthcare provider will receive the results from the lab and discuss them with you.

The IHC - CD61 test may be conducted alongside other diagnostic tests, including additional IHC tests, blood tests, or imaging studies, to provide a more comprehensive understanding of your health.

While the IHC - CD61 test can provide valuable information about certain types of cancer, it should be used as part of a larger diagnostic process and not as a standalone test for cancer.

A high or low level of CD61 does not confirm a specific disease but can suggest a potential health condition that needs further investigation.

Several factors can affect the results of the test, including the quality of the tissue sample, the staining process, and individual variations in protein expression.

If your test result is abnormal, you may need to consult with a hematologist, an oncologist, or another specialist, depending on the nature of your results and your overall health.

Understanding the cellular components of a tissue sample is a critical part of diagnosing and monitoring various health conditions. The IHC - CD61 test offers valuable insight into the presence and number of cells expressing CD61, providing a helpful tool in the medical toolbox. As with any test, the results should be interpreted in the context of your overall health and other test results.